SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe disease

被引：87

作者：

Wang, Pengfei ^{[1
]}

Liu, Lihong ^{[1
]}

Nair, Manoj S. ^{[1
]}

Yin, Michael T. ^{[2
]}

Luo, Yang ^{[1
]}

Wang, Qian ^{[3
]}

Yuan, Ting ^{[1
]}

Mori, Kanako ^{[1
]}

Solis, Axel Guzman ^{[1
]}

Yamashita, Masahiro ^{[1
]}

Garg, Ankur ^{[4
]}

Purpura, Lawrence J. ^{[2
]}

Laracy, Justin C. ^{[2
]}

Yu, Jian ^{[1
]}

Joshua-Tor, Leemor ^{[4
]}

Sodroski, Joseph ^{[3
]}

Huang, Yaoxing ^{[1
]}

Ho, David D. ^{[1
]}

机构：

[1] Columbia Univ, Vagelos Coll Phys & Surg, Aaron Diamond AIDS Res Ctr, 701 W 168th St, New York, NY 10032 USA

[2] Columbia Univ, Vagelos Coll Phys & Surg, Dept Internal Med, Div Infect Dis, New York, NY USA

[3] Harvard Med Sch, Dept Microbiol, Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02115 USA

[4] Cold Spring Harbor Lab, WM Keck Struct Biol Lab, POB 100, Cold Spring Harbor, NY 11724 USA

来源：

EMERGING MICROBES & INFECTIONS | 2020年 / 9卷 / 01期

基金：

美国国家卫生研究院;

关键词：

SARS-CoV-2; antibody; neutralization; severe; non-severe;

D O I：

10.1080/22221751.2020.1823890

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

We studied plasma antibody responses of 35 patients about 1 month after SARS-CoV-2 infection. Titers of antibodies binding to the viral nucleocapsid and spike proteins were significantly higher in patients with severe disease. Likewise, mean antibody neutralization titers against SARS-CoV-2 pseudovirus and live virus were higher in the sicker patients, by similar to 5-fold and similar to 7-fold, respectively. These findings have important implications for those pursuing plasma therapy, isolation of neutralizing monoclonal antibodies, and determinants of immunity.

引用

页码：2091 / 2093

页数：3

共 50 条

[21] SARS-CoV-2 antibody responses in patients with acute leukaemia
J. O’Nions
L. Muir
J. Zheng
C. Rees-Spear
A. Rosa
C. Roustan
C. Earl
P. Cherepanov
R. Gupta
A. Khwaja
C. Jolly
L. E. McCoy
Leukemia, 2021, 35 : 289 - 292
[22] SARS-CoV-2 antibody responses in patients with acute leukaemia
O'Nions, J.
Muir, L.
Zheng, J.
Rees-Spear, C.
Rosa, A.
Roustan, C.
Earl, C.
Cherepanov, P.
Gupta, R.
Khwaja, A.
Jolly, C.
McCoy, L. E.
LEUKEMIA, 2021, 35 (01) : 289 - 292
[23] Evasion of neutralizing antibody responses by the SARS-CoV-2 BA.2.75 variant
Qu, Panke
Evans, John P.
Zheng, Yi-Min
Carlin, Claire
Saif, Linda J.
Oltz, Eugene M.
Xu, Kai
Gumina, Richard J.
Liu, Shan-Lu
CELL HOST & MICROBE, 2022, 30 (09) : 1518 - +
[24] SARS-COV-2 NEUTRALIZING ANTIBODY RESPONSE TO BOOSTER VACCINATION IN PATIENTS ON HEMODIALYSIS
Wang, Xiaoling
Han, Maggie
Wang, Kevin
Thwin, Ohnmar
Rivera-Fuentes, Lemuel
Haq, Zahin
Grobe, Nadja
Wang, Yuedong
Kotanko, Peter
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I667 - I668
[25] Antibody responses to SARS-CoV-2 in patients with differing severities of coronavirus disease 2019
Kowitdamrong, Ekasit
Puthanakit, Thanyawee
Jantarabenjakul, Watsamon
Prompetchara, Eakachai
Suchartlikitwong, Pintip
Putcharoen, Opass
Hirankarn, Nattiya
PLOS ONE, 2020, 15 (10):
[26] Neutralizing antibody responses and cellular responses against SARS-CoV-2 Omicron subvariants after mRNA SARS-CoV-2 vaccination in kidney transplant recipients
Kawashiro, Keita
Suzuki, Rigel
Nogimori, Takuto
Tsujino, Shuhei
Iwahara, Naoya
Hirose, Takayuki
Okada, Kazufumi
Yamamoto, Takuya
Fukuhara, Takasuke
Hotta, Kiyohiko
Shinohara, Nobuo
SCIENTIFIC REPORTS, 2024, 14 (01):
[27] Strong Neutralizing Antibody Responses to SARS-CoV-2 Variants Following a Single Vaccine Dose in Subjects With Previous SARS-CoV-2 Infection
Ekstrom, Nina
Haveri, Anu
Solastie, Anna
Virta, Camilla
Osterlund, Pamela
Nohynek, Hanna
Nieminen, Tuomo
Ivaska, Lauri
Tahtinen, Paula A.
Lempainen, Johanna
Jalkanen, Pinja
Julkunen, Ilkka
Palmu, Arto A.
Melin, Merit
OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (12):
[28] SARS-CoV-2 mRNA vaccination elicits robust antibody responses in children
Bartsch, Yannic C.
St Denis, Kerri J.
Kaplonek, Paulina
Kang, Jaewon
Lam, Evan C.
Burns, Madeleine D.
Farkas, Eva J.
Davis, Jameson P.
Boribong, Brittany P.
Edlow, Andrea G.
Fasano, Alessio
Shreffler, Wayne G.
Zavadska, Dace
Johnson, Marina
Goldblatt, David
Balazs, Alejandro B.
Yonker, Lael M.
Alter, Galit
SCIENCE TRANSLATIONAL MEDICINE, 2022, 14 (672)
[29] Mild SARS-CoV-2 Infections and Neutralizing Antibody Titers
Bonfante, Francesco
Costenaro, Paola
Cantarutti, Anna
Di Chiara, Costanza
Bortolami, Alessio
Petrara, Maria Raffaella
Carmona, Francesco
Pagliari, Matteo
Cosma, Chiara
Cozzani, Sandra
Mazzetto, Eva
Di Salvo, Giovanni
Da Dalt, Liviana
Palma, Paolo
Barzon, Luisa
Corrao, Giovanni
Terregino, Calogero
Padoan, Andrea
Plebani, Mario
De Rossi, Anita
Dona, Daniele
Giaquinto, Carlo
PEDIATRICS, 2021, 148 (03)
[30] Rational optimization of a human neutralizing antibody of SARS-CoV-2
Chen, Jiao
Wu, Fei
Lin, Dan
Kong, Weikang
Cai, Xueting
Yang, Jie
Sun, Xiaoyan
Cao, Peng
COMPUTERS IN BIOLOGY AND MEDICINE, 2021, 135

← 1 2 3 4 5 →